glp-1 obesity drug news today september 15 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 The FDA approved a new

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as monotherapy or add-on to metformin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Oncol Rep

Any opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients

Colonic delivery of -linolenic acid by an advanced nutrient delivery system prolongs glucagon-like peptide-1 secretion and inhibits food intake in mice

The projected uptake of GLP-1RAs in the geographies relevant to their business and how this may change under different scenarios